PMID- 10323407 OWN - NLM STAT- MEDLINE DCOM- 19990527 LR - 20111117 IS - 0021-972X (Print) IS - 0021-972X (Linking) VI - 84 IP - 5 DP - 1999 May TI - Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes. PG - 1722-8 AB - The human leukocyte antigen (HLA)-DQA1*0102/DQB1*0602/DRB1*1501 (DR2) haplotype confers strong protection from type 1 diabetes. Growing evidence suggests that such protection may be mostly encoded by the DQB1*0602 allele, and we reported that even first degree relatives with islet cell antibodies (ICA) have an extremely low diabetes risk if they carry DQB1*0602. Recently, novel variants of the DQB1*0602 and *0603 alleles were reported in four patients with type 1 diabetes originally typed as DQB1*0602 with conventional techniques. One inference from this observation is that DQB1*0602 may confer absolute protection and may never occur in type 1 diabetes. By this hypothesis, all patients typed as DQB1*0602 positive with conventional techniques should carry one of the above diabetes-permissive variants instead of the protective DQB1*0602. Such variants could also occur in ICA/DQB1*0602-positive relatives, with the implication that their diabetes risk could be significantly higher than previously estimated. We therefore sequenced the DQB1*0602 and DQA1*0102 alleles in all ICA/DQB1*0602-positive relatives (n = 8) previously described and in six rare patients with type 1 diabetes and DQB1*0602. We found that all relatives and patients carry the known DQB1*0602 and DQA1*0102 sequences, and none of them has the mtDNA A3243G mutation associated with late-onset diabetes in ICA-positive individuals. These findings suggest that diabetes-permissive DQB1*0602/3 variants may be very rare. Thus, although the protective effect associated with DQB1*0602 is extremely powerful, it is not absolute. Nonetheless, the development of diabetes in individuals with DQB1*0602 remains extremely unlikely, even in the presence of ICA, as confirmed by our further evaluation of ICA/DQB1*0602-positive relatives, none of whom has yet developed diabetes. FAU - Pugliese, A AU - Pugliese A AD - Diabetes Research Institute, University of Miami School of Medicine, Florida 33136, USA. apuglies@mednet.med.miami.edu FAU - Kawasaki, E AU - Kawasaki E FAU - Zeller, M AU - Zeller M FAU - Yu, L AU - Yu L FAU - Babu, S AU - Babu S FAU - Solimena, M AU - Solimena M FAU - Moraes, C T AU - Moraes CT FAU - Pietropaolo, M AU - Pietropaolo M FAU - Friday, R P AU - Friday RP FAU - Trucco, M AU - Trucco M FAU - Ricordi, C AU - Ricordi C FAU - Allen, M AU - Allen M FAU - Noble, J A AU - Noble JA FAU - Erlich, H A AU - Erlich HA FAU - Eisenbarth, G S AU - Eisenbarth GS LA - eng GR - DK32083/DK/NIDDK NIH HHS/United States GR - MO1RR00069/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Autoantibodies) RN - 0 (DNA, Mitochondrial) RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DQB1 antigen) RN - 0 (islet cell antibody) SB - IM MH - Adult MH - Alleles MH - Autoantibodies/analysis/*genetics MH - Base Sequence MH - DNA, Mitochondrial/analysis/genetics MH - Diabetes Mellitus, Type 1/*genetics/immunology MH - Female MH - Follow-Up Studies MH - HLA-DQ Antigens/*genetics MH - HLA-DQ beta-Chains MH - Humans MH - Islets of Langerhans/*immunology MH - Male MH - Molecular Sequence Data MH - Mutation EDAT- 1999/05/14 00:00 MHDA- 1999/05/14 00:01 CRDT- 1999/05/14 00:00 PHST- 1999/05/14 00:00 [pubmed] PHST- 1999/05/14 00:01 [medline] PHST- 1999/05/14 00:00 [entrez] AID - 10.1210/jcem.84.5.5684 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 1999 May;84(5):1722-8. doi: 10.1210/jcem.84.5.5684.